BiotechTube
Home/Targazyme/Lijun Xia, MD, PhD
LX

Lijun Xia, MD, PhD

Scientific Founder, Board Member

Targazyme

Therapeutic Areas

OncologyAutoimmune DiseasesNeurodegenerative Diseases

Targazyme Pipeline

DrugIndicationPhase
TZ-101 PlatformCell Therapy Enhancement (Oncology, Autoimmune, Neurodegenerative)Pre-clinical

Leadership Team at Targazyme

LK
Lynnet Koh
Chairman & CEO
CO
Chuck Olson, PhD
Chief Technology Officer
PG
Paul Grint, MD
Acting Chief Medical Officer & Medical Board Chair
RM
Rodger McEver, MD
Scientific Founder, Board Member
View full Targazyme profile